Department of Stomatology, Shanghai Jiading Central Hospital, China.
Cell Signal. 2012 Oct;24(10):1889-98. doi: 10.1016/j.cellsig.2012.05.017. Epub 2012 Jun 6.
The uptake of oxidized low density lipoprotein (ox-LDL) by macrophages usually leads to the formation of lipid-laden macrophages known as "foam cells," and this process plays an important role in the development of atherosclerosis. Ox-LDL activates mitogen-activated protein kinase (MAP) kinases and nuclear factor (NF)-κB, and activations of p38 and NF-κB are important for the formation of foam cells. MAP kinase phosphatase (MKP) 5 is a member of the dual specificity phosphatases (DUSPs) family that can selectively dephosphorylate activated MAPKs to regulate innate and adaptive immune responses. However, the role of MKP5 in the formation of foam cells remains unknown. Here, we found that stimulation of ox-LDL induces the expression of MKP5 in macrophages. MKP5 deficiency blocked the uptake of ox-LDL and the formation of foam cells. Further analysis revealed that deletion of MKP5 reduced the ox-LDL-induced activation of NF-κB. Also, MKP5 deficiency markedly inhibited the production of TNF-α, but enhanced the levels of TGF-β1 in ox-LDL-stimulated macrophages. Moreover, inhibition of NF-κB by p65 RNAi significantly reduced foam cell formation in macrophages from WT mice relative to MKP5-deficient mice. Thus, MKP5 has an essential role in the formation of foam cells through activation of NF-κB, and MKP5 represents a novel target for the therapeutic intervention of atherosclerosis.
巨噬细胞摄取氧化型低密度脂蛋白(ox-LDL)通常会导致富含脂质的巨噬细胞形成,这些细胞被称为“泡沫细胞”,这个过程在动脉粥样硬化的发展中起着重要作用。ox-LDL 激活丝裂原活化蛋白激酶(MAP)激酶和核因子(NF)-κB,p38 和 NF-κB 的激活对于泡沫细胞的形成很重要。MAP 激酶磷酸酶(MKP)5 是双特异性磷酸酶(DUSPs)家族的成员,可选择性地去磷酸化激活的 MAPK 以调节先天和适应性免疫反应。然而,MKP5 在泡沫细胞形成中的作用尚不清楚。在这里,我们发现 ox-LDL 刺激诱导巨噬细胞中 MKP5 的表达。MKP5 缺陷阻止了 ox-LDL 的摄取和泡沫细胞的形成。进一步的分析表明,MKP5 的缺失减少了 ox-LDL 诱导的 NF-κB 的激活。此外,MKP5 缺陷显著抑制了 ox-LDL 刺激的巨噬细胞中 TNF-α的产生,但增加了 TGF-β1 的水平。此外,与 MKP5 缺陷型小鼠相比,用 p65 RNAi 抑制 NF-κB 可显著减少 WT 小鼠巨噬细胞中的泡沫细胞形成。因此,MKP5 通过激活 NF-κB 在泡沫细胞形成中起重要作用,MKP5 是动脉粥样硬化治疗干预的新靶点。